Other specific arthropathies

M13_OTERSPECARTHR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M12.8 Hospital discharge: ICD-9 — 7164 Cause of death: ICD-10 — M12.8 Cause of death: ICD-9 — 7164 2 out of 7 registries used, show all original rules.	71
4. Check minimum number of events None	71
5. Include endpoints None	71
6. Filter based on genotype QC (FinnGen only)	71

Control definitions (FinnGen only)

Control exclude: M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M12
Name in latin: Aliae arthropathiae specificae non alibi classificatae

NAME	M13_OTERSPECARTHR
CONTROL_EXCLUDE	M13_ARTHROPATHIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M128
HD_ICD_9	7164
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M128
COD_ICD_9	7164
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specific arthropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	538	264	268
Only index persons	487	239	248
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	43.11	48.62	37.31
Only index persons	39.19	46.04	32.59

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	71	40	31
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	45.98	46.23	45.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
66: Matched controls
661

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M12.8

ICD-10 Finland

Other specific arthropathies, not elsewhere classified

+∞

67.8

7164A

ICD-9 Finland

Other and unspecified arthropathies, Transient arthropathy

+∞

14.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

24.0

12.9

M19.0

ICD-10 Finland

Primary arthrosis of other joints

79.2

12.1

M17.1

ICD-10 Finland

Other primary gonarthrosis

24.8

10.3

A07EC01

ATC

sulfasalazine; oral, rectal

24.8

10.3

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

17.1

9.7

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

+∞

9.6

M13.9

ICD-10 Finland

Arthritis, unspecified

19.7

9.0

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

102.3

8.6

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

102.3

8.6

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

102.3

8.6

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

38.5

8.3

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

25.8

8.3

M25.5

ICD-10 Finland

Pain in joint

6.3

8.1

P01BA02

ATC

hydroxychloroquine; oral

21.5

7.9

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

+∞

7.4

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

+∞

7.4

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

34.0

7.3

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

76.7

6.5

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

29.7

6.4

L88

ICPC

Rheumatoid/seropositive arthritis

29.7

6.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

11.7

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

5.54

8.92

1.6

1.4

448.0

280.0

titre

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4.39

7.38

1.2

34.2

1.2

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4.45

7.32

1.2

1.3

16.9

13.3

iu/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

6.70

3.96

1.1

1.2

0.3

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

6.27

3.79

1.1

1.2

1.3

1.2

g/l

—

(36660697) Celiac disease serology panel - Serum

3.56

3.58

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

6.28

3.45

1.4

1.7

—

(42870588) Differential panel, method unspecified - Blood

169

2.34

2.95

9.8

4.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3.59

2.89

7.4

4.0

2.0

1.0

mmol/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.84

2.60

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

362

2.29

2.57

5.8

3.9

—

(40758558) Short blood count panel - Blood

131

2.26

2.48

11.6

7.3

—

(3022313) Gas panel - Capillary blood

3.33

2.08

6.4

3.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.71

2.04

6.5

1.6

9.7

9.8

g/l

0.02

(3013512) EKG study

143

2.02

1.94

4.0

3.5

—

(3035350) Ketones [Presence] in Urine by Test strip

262

1.86

1.77

3.3

3.1

0.0

estimate

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

262

1.86

1.77

7.9

7.4

1.2

mmol/l

0.15

213

(3022145) Colonoscopy Study observation

2.33

1.66

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.76

1.64

1.2

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

3.18

1.62

2.8

1.6

—

(3049717) Cytology report of Urine Cyto stain

3.18

1.62

2.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

111

1.97

1.59

3.3

2.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

241

1.79

1.57

5.9

5.4

1.2

mmol/l

0.01

222

(3008898) HLA-B27 [Presence]

3.50

1.55

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3.50

1.55

2.0

1.2

28.4

37.3

nmol/l

—

(3045414) Leukocytes [Presence] in Urine

3.02

1.54

2.7

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

189

1.80

1.51

2.1

1.9

85.6

97.6

pmol/l

0.95

(3015736) pH of Urine

198

1.79

1.51

2.6

2.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

155

1.83

1.49

4.1

1.9

128.6

139.4

u/l

0.14

148

(3012516) Albumin [Mass/volume] in Urine

151

1.77

1.34

3.2

238.1

486.7

mg/l

0.23

(3000330) Specific gravity of Urine by Test strip

2.63

1.33

3.2

4.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

260

1.68

1.31

4.6

4.2

0.0

estimate

—

(3019225) pH of Specimen

2.21

1.29

4.9

5.3

—

(3032080) INR in Blood by Coagulation assay

191

1.67

1.20

7.0

8.2

1.3

1.2

inr

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

183

1.66

1.17

5.2

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

554

1.94

1.16

16.7

11.4

79.9

84.4

ml/min/173m2

0.80

456

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.07

1.13

1.4

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.09

1.09

2.4

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1.95

1.05

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.78

1.04

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.11

1.03

1.7

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

382

1.58

1.00

3.1

3.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.87

0.99

1.8

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.25

0.94

2.3

2.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

159

1.56

0.86

4.8

4.1

46.9

8.5

mg/mmol

0.64

102

(40761535) Cells panel - Urine sediment

1.79

0.84

5.1

3.0

—

(36304419) Bacteria [Presence] in Urine

143

1.55

0.82

4.0

2.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

207

1.49

0.81

3.7

3.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.70

0.77

3.4

1.8

—

(3000494) Fungus identified in Specimen by Culture

1.69

0.76

2.0

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

238

1.45

0.75

3.4

3.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.66

0.74

1.2

1.5

—

(3018095) Leukocytes [#/volume] in Urine

183

1.47

0.73

4.6

3.2

13.5

234.9

e6/l

0.60

122

(3023368) Bacteria identified in Blood by Culture

129

1.53

0.73

5.9

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

123

1.50

0.66

2.2

1.5

1.9

2.4

g/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.78

0.65

3.6

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

597

1.73

0.64

20.7

13.9

4.0

mmol/l

0.01

582

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.59

0.0

1.6

—

330.7

—

(3022621) pH of Urine by Test strip

1.73

0.58

2.7

2.8

—

(40768804) Tissue Pathology biopsy report

238

1.37

0.57

1.7

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.68

0.57

1.8

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.55

0.54

1.4

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

157

1.38

0.51

2.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

419

0.76

0.50

4.2

2.7

51.7

48.5

u/l

0.11

396

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.52

0.47

1.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.38

0.42

1.8

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.41

0.0

2.8

—

134.5

—

(3019060) Gas panel - Arterial blood

1.51

0.41

2.6

5.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

596

1.51

0.41

20.9

13.8

139.4

139.8

mmol/l

0.48

580

(3026008) Bacteria identified in Urine by Culture

144

1.33

0.40

3.3

3.0

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.40

0.0

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.39

0.0

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.62

0.38

1.0

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.47

0.36

1.7

1.8

—

(40761511) CBC panel - Blood by Automated count

621

1.55

0.35

18.8

11.5

—

(3000492) Spirometry study

1.36

0.35

4.3

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.29

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.28

0.29

2.0

4.3

6.4

umol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.26

0.28

7.9

6.8

—

(40768797) Stomach Pathology biopsy report

1.29

0.27

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.30

0.23

1.8

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.30

0.23

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

103

0.75

0.23

1.5

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

3.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.25

0.19

3.3

3.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.75

0.18

1.0

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

540

1.18

0.16

19.2

12.9

38.4

40.4

0.62

400

(40760892) CBC W Ordered Manual Differential panel - Blood

124

1.16

0.12

3.2

4.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.19

0.11

1.8

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.17

0.10

1.8

1.4

—

(3012544) pH of Venous blood

1.12

0.10

3.0

4.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

117

1.14

0.09

2.5

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

127

1.13

0.08

3.9

4.5

23.1

20.8

—

(3044889) 12 lead EKG panel

401

1.05

0.03

3.7

—

(3044640) Blood type and Crossmatch panel - Blood

162

0.98

0.00

2.3

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

188

1.01

0.00

2.6

2.2

55.5

55.1

u/l

0.02

173

(1761868) Lipid panel - Serum or Plasma

229

1.01

0.00

3.0

—

(3003694) ABO and Rh group [Type] in Blood

156

1.03

0.00

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.4

—

(4062490)

0.00

0.0

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.1

—

(4281824)

0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(44790049)

0.00

0.0

1.4

—

(44790048)

0.00

0.0

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

20.3

—

1743.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

3.0

—

65.1

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.0

—

(44790047)

0.00

0.0

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

0.8

—

(21494755) Public health laboratory ask at order entry panel

1.01

0.00

1.1

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

6.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.9

—

165.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

2.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.9

—

(44806118)

0.00

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1.02

0.00

2.3

1.9

120.8

33.8

u/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.3

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

17.6

—

960.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

11.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.9

—

13.7

—

(3011648) Oxygen content in Venous blood

0.00

0.0

1.8

—

14.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OTERSPECARTHR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_OTERSPECARTHR.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_OTERSPECARTHR – Other specific arthropathies

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specific arthropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints